Viewing Study NCT06756932

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-24 @ 9:43 PM
Ignite Modification Date: 2026-01-04 @ 12:19 PM
Study NCT ID: NCT06756932
Status: RECRUITING
Last Update Posted: 2025-11-10
First Post: 2024-12-24
Is NOT Gene Therapy: True
Has Adverse Events: False
Brief Title: BGB-21447 (Bcl-2 Inhibitor) Combinations for Adults With Hormone-Receptor Positive (HR+)/Human Epidermal Growth Factor Receptor 2 Negative (HER2-) Metastatic Breast Cancer
Sponsor: BeOne Medicines
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Hormone-receptor-positive Breast Cancer View
None HER2-negative Breast Cancer View
None Metastatic Breast Cancer View
Keywords:

Keywords

Keyword Brief Keyword Text View
None BGB-21447 View
None BGB-43395 View
None metastatic breast cancer View
None Bcl-2i View
None CDK4i View